Literature DB >> 20541404

Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors.

Michael K Ameriks1, Scott D Bembenek, Matthew T Burdett, Ingrid C Choong, James P Edwards, Damara Gebauer, Yin Gu, Lars Karlsson, Hans E Purkey, Bart L Staker, Siquan Sun, Robin L Thurmond, Jian Zhu.   

Abstract

A pyridazin-4-one fragment 4 (hCatS IC(50)=170 microM) discovered through Tethering was modeled into cathepsin S and predicted to overlap in S2 with the tetrahydropyridinepyrazole core of a previously disclosed series of CatS inhibitors. This fragment served as a template to design pyridazin-3-one 12 (hCatS IC(50)=430 nM), which also incorporates P3 and P5 binding elements. A crystal structure of 12 bound to Cys25Ser CatS led to the synthesis of the potent diazinone isomers 22 (hCatS IC(50)=60 nM) and 27 (hCatS IC(50)=40 nM). 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541404     DOI: 10.1016/j.bmcl.2010.05.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Calculate protein-ligand binding affinities with the extended linear interaction energy method: application on the Cathepsin S set in the D3R Grand Challenge 3.

Authors:  Xibing He; Viet H Man; Beihong Ji; Xiang-Qun Xie; Junmei Wang
Journal:  J Comput Aided Mol Des       Date:  2018-09-14       Impact factor: 3.686

2.  Blinded prediction of protein-ligand binding affinity using Amber thermodynamic integration for the 2018 D3R grand challenge 4.

Authors:  Junjie Zou; Chuan Tian; Carlos Simmerling
Journal:  J Comput Aided Mol Des       Date:  2019-09-25       Impact factor: 3.686

3.  Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm.

Authors:  Prabhakar K Jadhav; Matthew A Schiffler; Kostas Gavardinas; Euibong J Kim; Donald P Matthews; Michael A Staszak; D Scott Coffey; Bruce W Shaw; Kenneth C Cassidy; Richard A Brier; Yuke Zhang; Robert M Christie; William F Matter; Keyun Qing; Jim D Durbin; Yong Wang; Gary G Deng
Journal:  ACS Med Chem Lett       Date:  2014-08-27       Impact factor: 4.345

4.  Generative network complex (GNC) for drug discovery.

Authors:  Christopher Grow; Kaifu Gao; Duc Duy Nguyen; Guo-Wei Wei
Journal:  Commun Inf Syst       Date:  2019

5.  The role of human in the loop: lessons from D3R challenge 4.

Authors:  Oleg V Stroganov; Fedor N Novikov; Michael G Medvedev; Artem O Dmitrienko; Igor Gerasimov; Igor V Svitanko; Ghermes G Chilov
Journal:  J Comput Aided Mol Des       Date:  2020-01-21       Impact factor: 3.686

6.  Predicting binding poses and affinity ranking in D3R Grand Challenge using PL-PatchSurfer2.0.

Authors:  Woong-Hee Shin; Daisuke Kihara
Journal:  J Comput Aided Mol Des       Date:  2019-09-10       Impact factor: 3.686

7.  Using Fragment-Based Approaches to Discover New Antibiotics.

Authors:  Bas Lamoree; Roderick E Hubbard
Journal:  SLAS Discov       Date:  2018-07       Impact factor: 3.341

8.  Protein-ligand pose and affinity prediction: Lessons from D3R Grand Challenge 3.

Authors:  Panagiotis I Koukos; Li C Xue; Alexandre M J J Bonvin
Journal:  J Comput Aided Mol Des       Date:  2018-08-20       Impact factor: 3.686

9.  Benchmarking ensemble docking methods in D3R Grand Challenge 4.

Authors:  Jessie Low Gan; Dhruv Kumar; Cynthia Chen; Bryn C Taylor; Benjamin R Jagger; Rommie E Amaro; Christopher T Lee
Journal:  J Comput Aided Mol Des       Date:  2022-02-24       Impact factor: 3.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.